3/26
08:49 am
clgn
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]
High
Report
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]
3/26
08:30 am
clgn
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
High
Report
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
3/24
04:46 pm
clgn
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement [Yahoo! Finance]
Medium
Report
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement [Yahoo! Finance]
3/24
04:01 pm
clgn
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
Medium
Report
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
3/18
09:00 am
clgn
CollPlant Biotechnologies Launches Redesigned Corporate Website
Medium
Report
CollPlant Biotechnologies Launches Redesigned Corporate Website
3/11
08:00 am
clgn
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
Low
Report
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
2/26
07:02 pm
clgn
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler [Yahoo! Finance]
Low
Report
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler [Yahoo! Finance]
2/26
08:00 am
clgn
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
Medium
Report
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
2/23
07:00 am
clgn
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
Medium
Report
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
2/17
07:00 am
clgn
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
High
Report
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
2/6
08:11 am
clgn
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering [Yahoo! Finance]
Neutral
Report
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering [Yahoo! Finance]
2/6
08:04 am
clgn
CollPlant Biotechnologies (NASDAQ:CLGN) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
Neutral
Report
CollPlant Biotechnologies (NASDAQ:CLGN) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
2/5
08:00 am
clgn
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
High
Report
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING